Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Vermeire

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Antiviral Research|March 28, 2023
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutantsEmiel Vanhulle, Jordi Doijen, Joren Stroobants, et al.
AIDS Research and Human Retroviruses|January 8, 2004
The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression levelKatrien Princen, Sigrid Hatse, Kurt Vermeire, et al.
Virology|July 18, 2021
Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membraneMerel Oeyen, Eef Meyen, Sam Noppen, et al.
Frontiers in Immunology|May 10, 2021
Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T LymphocytesElisa Claeys, Eva Pauwels, Stephanie Humblet-Baron, et al.
Planta Medica|November 3, 2016
Chlorogenic Compounds from Coffee Beans Exert Activity against Respiratory VirusesValentina Sinisi, Annelies Stevaert, Federico Berti, et al.
Journal of Medicinal Chemistry|March 15, 2016
Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating PotenciesReena Chawla, Victor Van Puyenbroeck, Nicholas C Pflug, et al.
Organic & Biomolecular Chemistry|September 5, 2015
Metal complexes of pyridine-fused macrocyclic polyamines targeting the chemokine receptor CXCR4Sunil Hamal, Thomas D'huys, William F Rowley, et al.
Current HIV Research|May 14, 2008
CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptorKurt Vermeire, Joachim Brouwers, Yven Van Herrewege, et al.
Traffic (Copenhagen, Denmark)|November 2, 2019
Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamideVictor Van Puyenbroeck, Eva Pauwels, Becky Provinciael, et al.
Biochemical Pharmacology|July 3, 2007
Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activityKurt Vermeire, Andrea Lisco, Jean-Charles Grivel, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Antiviral Research|March 28, 2023
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutantsEmiel Vanhulle, Jordi Doijen, Joren Stroobants, et al.
AIDS Research and Human Retroviruses|January 8, 2004
The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression levelKatrien Princen, Sigrid Hatse, Kurt Vermeire, et al.
Virology|July 18, 2021
Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membraneMerel Oeyen, Eef Meyen, Sam Noppen, et al.
Frontiers in Immunology|May 10, 2021
Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T LymphocytesElisa Claeys, Eva Pauwels, Stephanie Humblet-Baron, et al.
Planta Medica|November 3, 2016
Chlorogenic Compounds from Coffee Beans Exert Activity against Respiratory VirusesValentina Sinisi, Annelies Stevaert, Federico Berti, et al.
Journal of Medicinal Chemistry|March 15, 2016
Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating PotenciesReena Chawla, Victor Van Puyenbroeck, Nicholas C Pflug, et al.
Organic & Biomolecular Chemistry|September 5, 2015
Metal complexes of pyridine-fused macrocyclic polyamines targeting the chemokine receptor CXCR4Sunil Hamal, Thomas D'huys, William F Rowley, et al.
Current HIV Research|May 14, 2008
CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptorKurt Vermeire, Joachim Brouwers, Yven Van Herrewege, et al.
Traffic (Copenhagen, Denmark)|November 2, 2019
Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamideVictor Van Puyenbroeck, Eva Pauwels, Becky Provinciael, et al.
Biochemical Pharmacology|July 3, 2007
Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activityKurt Vermeire, Andrea Lisco, Jean-Charles Grivel, et al.
Pageof 9